Farther Finance Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-131
Closed -$152 2594
2023
Q1
$152 Sell
131
-155
-54% -$283 ﹤0.01% 2242
2022
Q4
$766 Buy
+286
New +$754 ﹤0.01% 1715

Other funds holding CELL

Farther Finance Advisors's CELL Position: Q2 2023 in Review

Farther Finance Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 131 shares — an estimated $152 sold.

Farther Finance Advisors first reported a position in CELL in Q4 2022 and held it in 2 quarters. The position peaked at $766 in Q4 2022. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Farther Finance Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Farther Finance Advisors sold 131 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $152.
  • Farther Finance Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Farther Finance Advisors's PhenomeX Inc. Common Stock position peaked at $766 in Q4 2022.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Farther Finance Advisors's 13F filing for Q2 2023, filed 12 Sep 2023.